Stock Rich List
Nasdaq: DNLI

Denali Therapeutics insiders

The officers, directors and 10% owners of Denali Therapeutics Inc. who hold the most stock, valued at the live DNLI price.

$18.20
DNLI today −$200K (−1.09%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
8
Their DNLI stock
$127M
Market value
$2.92B
Held by ranked insiders
4.36%

Insiders by value of DNLI holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Ryan J. WattsPresident and CEO2,417,217$44.0M1.51%2788th
2Marc Tessier-LavigneDirector1,965,424$35.8M1.23%3118th
3Steve KrognesDirector819,999$14.9M0.51%6089th
4Alexander O. SchuthCOFO and Secretary819,310$14.9M0.51%6473rd
5Carole HoChief Medical Officer424,804$7.7M0.27%9813th
6Jay T. FlatleyDirector358,941$6.5M0.22%9871st
7Vicki L. SatoDirector107,976$2.0M<0.1%7843rd
8David P. SchenkeinDirector79,129$1.4M<0.1%6200th

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Denali Therapeutics; see each profile for the filing.